WELL HEALTH TECH CORP ORD - WHTCF STOCK NEWS

WELL Health Technologies Corp. (TSX: WELL) achieved record quarterly revenues of $204.5 million and record Adjusted EBITDA of $28.2 million in Q3-2023, marking its 19th consecutive quarter of record revenue performance. The Company surpassed 1.03 million patient visits and achieved almost 1.58 million total care interactions, with a YoY increase of 24% in Canadian business Adjusted EBITDA. WELL upgraded its guidance, expecting 2023 revenue between $755 million to $765 million and aiming to exceed $900 million in annual revenue in 2024 through organic growth. The PR also highlights WELL's strategic investments in AI and its strong financial performance, including an increase of 40.2% in quarterly revenue compared to Q3-2022.

WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) announces the launch of the WELL Longevity+ Program, a preventative care initiative utilizing advanced precision diagnostics and AI technologies for early detection of major chronic diseases. The program aims to improve early diagnosis of conditions like cancer, heart disease, and neurodegenerative diseases, initially available at the WELL Health Medical & Longevity Centre in Vancouver, BC, with plans for expansion throughout Canada.

WELL Health Technologies Corp. expects to announce record quarterly revenue in Q3-2023, driven by a record number of patient visits and Total Care Interactions. This strong performance was due to organic growth and recent acquisitions. Q3-2023 will be WELL's 19th consecutive quarter of record revenues. The company will announce its Third Quarter 2023 Financial Results on November 14, 2023.

WELL Health Technologies Corp.'s cybersecurity business unit, Cycura, has acquired Seekintoo and Proack to enhance patient data protection. Cycura now supports over 200,000 end-users and serves approximately 190 corporate and government entities across North America.

WELL Health Technologies Corp. announces the launch of WELL AI Decision Support, a new service for healthcare providers in partnership with HEALWELL AI.

WELL Health completes acquisition of HEALWELL's clinical assets in Ontario, adding over $21 million in yearly revenues. WELL invests $4 million in HEALWELL's convertible debenture offering. Strategic alliance formed to position HEALWELL as a healthcare technology leader. WELL appoints two representatives to HEALWELL's Board of Directors.

WELL Health Technologies Corp. and Orion Health announce strategic global partnership to enhance health integration tools

WELL Health Technologies Corp. (TSX: WELL) achieved record quarterly revenues of $170.9 million and record Adjusted EBITDA of $27.8 million in Q2-2023. The company surpassed 1 million patient visits for the first time and signed a $38.5 million contract for eReferral and eOrder technology services in British Columbia. WELL upgraded its 2023 revenue guidance to be in the upper half of $740 million to $760 million. The company also announced several key initiatives related to Artificial Intelligence, including WELL AI Voice and the WELL AI Investment Program.

WELL's subsidiary OceanMD has signed a $38.5 million contract with British Columbia's Provincial Health Services Authority to provide digital healthcare services. The Ocean Platform will streamline healthcare processes, improve efficiency for providers, and grant patients easier access to their health data.